Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidental versus clinically evident thyroid cancer: a 5-year follow-up study.
Minuto MN, Miccoli M, Viola D, Ugolini C, Giannini R, Torregrossa L, Antonangeli L, Aghini-Lombardi F, Elisei R, Basolo F, Miccoli P. Minuto MN, et al. Among authors: torregrossa l. Head Neck. 2013 Mar;35(3):408-12. doi: 10.1002/hed.22974. Epub 2012 Feb 24. Head Neck. 2013. PMID: 22367912
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F. Elisei R, et al. Among authors: torregrossa l. J Clin Endocrinol Metab. 2012 Dec;97(12):4390-8. doi: 10.1210/jc.2012-1775. Epub 2012 Oct 12. J Clin Endocrinol Metab. 2012. PMID: 23066120
Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.
Elisei R, Lorusso L, Romei C, Bottici V, Mazzeo S, Giani C, Fiore E, Torregrossa L, Insilla AC, Basolo F, Guerini A, Menghi A, Poletti A, Cugudda L, Vitti P. Elisei R, et al. Among authors: torregrossa l. J Clin Endocrinol Metab. 2013 Sep;98(9):3550-4. doi: 10.1210/jc.2013-1940. Epub 2013 Jul 16. J Clin Endocrinol Metab. 2013. PMID: 23861463
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Romei C, Tacito A, Molinaro E, Agate L, Bottici V, Viola D, Matrone A, Biagini A, Casella F, Ciampi R, Materazzi G, Miccoli P, Torregrossa L, Ugolini C, Basolo F, Vitti P, Elisei R. Romei C, et al. Among authors: torregrossa l. Clin Endocrinol (Oxf). 2015 Jun;82(6):892-9. doi: 10.1111/cen.12686. Epub 2014 Dec 29. Clin Endocrinol (Oxf). 2015. PMID: 25440022
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.
Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P, Torregrossa L, Sellari-Franceschini S, Basolo F, Vitti P, Elisei R, Miccoli P. Viola D, et al. Among authors: torregrossa l. J Clin Endocrinol Metab. 2015 Apr;100(4):1316-24. doi: 10.1210/jc.2014-3825. Epub 2015 Jan 15. J Clin Endocrinol Metab. 2015. PMID: 25590215 Clinical Trial.
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
Elisei R, Lorusso L, Piaggi P, Torregrossa L, Pellegrini G, Molinaro E, Agate L, Bottici V, Pani F, Cacciato Insilla A, Casella F, Ciampi R, Tognetti I, Materazzi G, Basolo F, Romei C. Elisei R, et al. Among authors: torregrossa l. Eur J Endocrinol. 2015 Sep;173(3):297-304. doi: 10.1530/EJE-15-0304. Epub 2015 Jun 1. Eur J Endocrinol. 2015. PMID: 26034076
128 results